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 Abstract 
 　 Chinese toon, or  Cedrela sinensis Juss. (Meliaceae), is a broad-leafed tree found in China and 
South Korea.  Gedunin ( 1 ) 1 is a limonoid that is abundant in plants in the Meliaceae family.  Gedunin 
( 1 ) is reported to have antimalarial activity comparable to that of quinine 2 .  However, gedunin-
type limonoid molecules have numerous functional groups and the reactivity of those groups is not 
known, so few studies have chemically modified gedunin-type limonoids.  Studies have examined 
the structure-activity relationship of ring B of gedunin-type limonoids by comparing similar natural 
limonoids.  Those studies found that the functional group at the 7 ― position affects whether gedunin-
type limonoids have antimalarial activity 2 ― 4 or whether they have biological activity, e.g. inhibiting 
insect growth 5 or intake 6 .  Gedunin ( 1 ) has an acetyl group at the 7 ― position and it has potent 
antimalarial activity.  When gedunin is acetylated ( 2 ), however, that activity is attenuated 2 .  In 
comparison to gedunin ( 1 ), its deacetylated form ( 2 ) has somewhat greater inhibition of growth and 
intake 5 .  Very few previous studies have compared the anti-tumor activity of limonoid analogues with 
a chemically modified ring B.  Thus, the current study used 7 ― deacetoxy ― 7α―hydroxygedunin ( 2 ) 
to obtain new findings regarding structure and activity relationships with anti-tumor activity.  This 
study synthesized 6 new analogues ( 3 - 8 ) by substituting an acyl group for the acetyl group at the 7 ―
 position on ring B, and this study examined their cytotoxic activity against murine P ― 388 leukemia 
cells.  Compounds with an acyl group in place of an acetyl group at the 7 ― position on ring B had more 
potent activity if they had more chlorine atoms. 
 Keywords:  Gedunin-type limonoids, 7 ― Deacetoxy ― 7α―hydroxygedunin, Acyl substitution, P ― 388 
murine leukemia cells 
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 1. Introduction 
 　 We previously isolated and determined the structure of 5 triterpenoids with an obacunone-type 
limonoid skeleton 7 , 7 triterpenoids with a gedunin-type limonoid skeleton 8 , 33 triterpenoids with 
an apotirucallane-type skeleton 9, 10 , and 5 triterpenoids with a tirucallane skeleton 10 from the seeds, 
leaves, branches, and bark of  Cedrela sinensis Juss. (Meliaceae).  The known compound gedunin ( 1 ) 
can be obtained in relative abundance from that plant.  A study has reported that gedunin ( 1 ) has  in 
vitro activity against the chloroquine-resistant K1 strain of  Plasmodium falciparum 3 .  Studies on the 
structure-activity relationship of gedunin-type limonoids 2 ― 6 have compared similar natural limonoids 
and they have synthesized derivatives by replacing the acetyl group at the 7 ― position and reducing the 
acetyl group at the 1 ― and 2 ― positions.  MacKinnon et al. examined the structure-activity relationship 
of compounds related to gedunin ( 1 ), and they indicated that elements such as the double bond 
between the acetyl groups at the 1 ― and 2 ― positions on ring A, the acetyl group at the 7 ― position on 
ring B, epoxides at the 14 ― and 15 ― position on ring D, and the furan ring in the side chain were crucial 
to the display of antimalarial activity 5 .  These findings were all based on assessment of the activity of 
derivatives that were easily obtained from gedunin ( 1 ). 
 　 Gedunin molecules have a number of functional groups, so we previously attempted to introduce 
fluorine atoms into gedunin-type limonoids through fluorination with diethylaminosulfur trifluoride 
(DAST) in order to determine the chemical reactivity of those limonoids and to synthesize limonoid 
analogues not found in nature 11 .  In order to determine the effects of the acetyl group at the 7 ― position 
in gedunin, the current study chemically transformed 7 ― deacetoxy ― 7α―hydroxygedunin ( 2 ) through 
acylation and synthesized 6 analogues.  The starting compound gedunin ( 1 ) is relatively abundant 
in the bark of  C. sinensis , so it can readily be obtained.  Gedunin can be deacetylated to obtain 7 ―
 deacetoxy ― 7α―hydroxygedunin ( 2 ). 
Gedunin型リモノイド7―deacetoxy―7α―hydroxygeduninの
7位に修飾したアナログの構造活性相関について
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 2. Results and Discussion 
 　 7 ― deacetoxy ― 7α―hydroxygedunin ( 2 ) was allowed to react with di- tert -butyldicarbonate {(COO- t -
Bu) 2 O} in pyridine for 24 h at room temperature in the presence of 4 ― dimethylaminopyridine (DMAP). 
This resulted in product  3 , with a yield of 53% (Scheme 1).  According to HRESIMS, this compound 
had a molecular formula of C 31 H 40 O 8 , and a signal due to a  tert -butyloxycarbonyl group {δ H 1.49 (s, 
9H),δ C 152.7 (C, C ― 1'), 83.0 (C, C ― 2'), 27.7 (3C, CH 3 , C ― 3')} was noted in  1 H- and  13 C-NMR spectra. 
 　 Similarly, compound  2 was allowed to react with propionic anhydride {(CH 3 CH 2 CO) 2 O} in pyridine 
for 24 h at room temperature in the presence of DMAP.  This resulted in product  4 , with a yield of 
86% (Scheme 1).  According to HRESIMS, the compound had a molecular formula of C 29 H 36 O 7 , and 
signals due to a propionyl group {δ H 2.35 (2H, m), 1.19 (3H, m), δ C 173.4 (C, C ― 1'), 28.0 (CH 2 , C ― 2'), 9.2 
(CH 3 , C ― 3')} were noted in  1 H- and  13 C-NMR spectra. 
 　 Similarly, compound  2 was allowed to react with butyric anhydride {[CH 3 (CH 2 ) 2 CO] 2 O} in pyridine 
for 24 h at room temperature in the presence of DMAP.  This resulted in product  5 , with a yield of 
93% (Scheme 1).  According to HRESIMS, the compound had a molecular formula of C 30 H 38 O 7 , and 
signals due to a butyryl group {δ H 2.30 (2H, m), 1.67 (2H, m), 0.96 (3H, t,  J ＝7.4 Hz),δ C 172.6 (C, C ―
 1'), 36.4 (CH 2 , C ― 2'), 18.4 (CH 2 , C ― 3'), 13.8 (CH 3 , C ― 4')} were noted in  1 H- and  13 C-NMR spectra. 
 　 Compound  2 was allowed to react with monochloroacetic acid anhydride {chloroacetic anhydride, 
(CH 2 ClCO) 2 O} in dichloromethane for 72 h at room temperature in the presence of DMAP.  This 
resulted in product  6 , with a yield of 66% (Scheme 1).  According to HRESIMS, this compound had a 
molecular formula of C 28 H 33 O 7 Cl, and a signal due to a chloroacetyl group {δ H 4.06 (2H, d,  J ＝1.8 Hz), 
δ C 166.3 (C, C ― 1'), 40.6 (CH 2 , C ― 2')} was noted in  1 H- and  13 C-NMR spectra. 
 　 Similarly, compound  2 was allowed to react with dichloroacetic anhydride {(CHCl 2 CO) 2 O} in 
dichloromethane for 72 h at room temperature in the presence of DMAP.  This resulted in product  7 , 
Fig. 1.  Structures of gedunin 
(1) and 7―deacetoxy―7α― 
hydroxygedunin (2).
― 28 ―
名古屋学院大学論集
with a yield of 53% (Scheme 1).  According to HRESIMS, this compound had a molecular formula of 
C 28 H 32 O 7 Cl 2 , and a signal due to a dichloroacetyl group {δ H 5.96 (s), δ C 163.3 (C, C ― 1'), 64.1 (CH, C ―
 2')} was noted in  1 H- and  13 C-NMR spectra. 
 　 Similarly, compound  2 was allowed to react with trichloroacetic anhydride {(CCl 3 CO) 2 O} in 
dichloromethane for 72 h at room temperature in the presence of DMAP.  This resulted in product  8 , 
with a yield of 51% (Scheme 1).  According to HRESIMS, this compound had a molecular formula of 
C 28 H 31 O 7 Cl 3 , and a signal due to a trichloroacetyl group {δ C 160.9 (C, C ― 1'), 90.4 (C, C ― 2')} was noted 
in the  13 C-NMR spectrum. 
 　 The synthesized limonoid analogues were then subjected to a cytotoxicity assay using cells from 
mice with P ― 388 leukemia (Table 1). 
 　 In analogues  3 ― 8 , an acyl group was transferred to the hydroxyl group at the 7 ― position, all of 
the analogues has more potent activity than that of compounds  1 and  2 .  Among these derivatives, 
compound  8 (which had a trichloroacetyl group) had 21 times the activity of compound  1 .  As findings 
of the structure-activity relationship by chemical modification of the gedunin-type limonoids, all of 
the derivatives had weaker cytotoxic activity than the IC 50 value of 0.029 μg/mL of mitomycin C. 
Furthermore, compounds with an acyl group in place of an acetyl group at the 7 ― position on ring B 
had more potent cytotoxic activity if they had more chlorine atoms. 
Scheme 1. Acylation of compound 2.a
Compound R Acylating agent Solvent/Catalyst (equiv) Time (h) Yield (%)
3
4
5
6
7
8
t-BuO
Et
n-Pr
CH2Cl
CHCl2
CCl3
(COO-t-Bu)2O
(CH3CH2CO)2O
[CH3(CH2)2CO]2O 
(CH2ClCO)2O
(CHCl2CO)2O
(CCl3CO)2O
Pyridine/DMAP (0.25)
Pyridine/DMAP (0.25)
Pyridine/DMAP (0.25)
CH2Cl2/DMAP (0.5)
CH2Cl2/DMAP (0.5)
CH2Cl2/DMAP (0.5)
24
24
24
72
72
72
53
86
93
66
53
51
a Reactions were carried out using 10 equiv of an acylating agent at room temperature.
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 Experimental 
 3.1. General 
 　 During this experiment, various types of data were obtained using the following equipment. 
 　 Melting point: Yanaco MP ― 3, Optical rotation ([α] D ): JASCO P ― 1030, Mass spectra (MS): Micromass 
LCT, Infrared (IR) absorption spectra: JASCO FT/IR 620, Ultraviolet (UV) absorption spectra: JASCO 
V ― 530, and Nuclear magnetic resonance (NMR) spectra: Bruker AM ― 500, DRX ― 500, and AV ― 600. 
NMR spectra were recorded by and data were processed using the software Bruker XWIN-NMR. 
A chemical shift (δ) was expressed in units of ppm.  Prydine- d 5 { 1 H: 7.21 ppm (C 5 D 4 HN),  13 C: 135.5 
ppm}, CDCl 3 { 
1 H: 7.26 ppm (CHCl 3 ),  
13 C: 77.03 ppm}, and CD 3 OD { 
1 H: 3.31 ppm (CD 2 HOD),  
13 C: 
49.0 ppm} were used as internal standards.  High-performance liquid chromatography (HPLC) was 
performed using the following system.  The pump used was the LC ― 6AD (Shimadzu).  Compounds 
were detected with the SPD ― 10A UV/vis detector (Shimadzu).  The column used was the Inertsil 
Prep-ODS (GL Sciences, Inc.) (6 mm i.d. ×250 mm, ODS, 10 μm, 20 mm i.d. ×250 mm, ODS, 10 
μm), the Wakosil-II 5C18HG (20 mm i.d. ×250 mm, ODS, 5 μm), or the Capcell Pak C18 UG 80 
(10 mm i.d. ×250 mm, ODS, 5 μm).  Cytotoxic activity against murine P ― 388 leukemia cells was 
measured using methods previously reported  12 . 
 3.2. Reaction procedures 
 3.2.1 Conversion of compound  2 into compound  3 
 　 Compound  2 (7 ― deacetoxy ― 7 ― hydroxygedunin, 10 mg, 0.023 mmol) was dissolved in pyridine (1 
mL), 4 ― dimethylaminopyridine (DMAP, 0.7 mg, 0.0057 mmol) and di- tert -butyldicarbonate {(COO-
 t -Bu) 2 O, 48μL, 0.22 mmol} were added, and the resulting mixture was stirred for 24 h at room 
temperature.  The solvent was removed under reduced pressure and the resulting residue was 
purified using ODS HPLC (MeOH/H 2 O 70:30), resulting in compound  3 (6.5 mg, 53%). 
 　 Compound  3 : Colorless, amorphous solid; [α] D28 ＋42 ( c 0.7, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ
Table 1. Cytotoxic activity of limonoid analogues against P―388 leukemia cells in vitro
Compound IC50 (μg/mL) Compound IC50 (μg/mL)
1
3
5
7
3.3
2.3
0.73
0.44
2
4
6
8
mitomycin C
4.5
1.9
0.54
0.16
0.029
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7.40 (1H, s, H ― 21), 7.40 (1H, m, H ― 23), 7.08 (1H, d,  J ＝10.2 Hz, H ― 1), 6.35 (1H, d,  J ＝0.86 Hz, H ― 22), 
5.85 (1H, d,  J ＝10.2 Hz, H ― 2), 5.58 (1H, s, H ― 17), 4.34 (1H, d,  J ＝1.4 Hz, H ― 7), 3.59 (1H, s, H ― 15), 2.49 
(1H, dd,  J ＝12.7, 5.9 Hz, H ― 9), 2.30 (1H, dd,  J ＝13.3, 2.3 Hz, H ― 5), 1.96 (1H, m, H ― 11), 1.93 (1H, m, H ― 
6), 1.83 (1H, m, H ― 11), 1.80 (1H, m, H ― 6), 1.70 (1H, m, H ― 12), 1.59 (1H, m, H ― 12), 1.49 (9H, s, OCO-
 t -Bu), 1.24 (3H, s, H 3 ― 18), 1.21 (3H, s, H 3 ― 19), 1.10 (3H, s, H 3 ― 30), 1.09 (3H, s, H 3 ― 28), 1.08 (3H, s, H 3
 ― 29);  13 C-NMR (125 MHz, CDCl 3 ) δ 204.1 (C, C ― 3), 167.0 (C, C ― 16), 157.1 (CH, C ― 1), 152.7 (C, C ― 
1'), 143.0 (CH, C ― 23), 141.2 (CH, C ― 21), 126.0 (CH, C ― 2), 120.6 (C, C ― 20), 110.0 (CH, C ― 22), 83.0 (C, 
C ― 2'), 78.2 (CH, C ― 17), 75.2 (CH, C ― 7), 69.8 (C, C ― 14), 56.9 (CH, C ― 15), 45.5 (CH, C ― 5), 44.1 (C, C ―
 4), 42.9 (C, C ― 8), 40.0 (C, C ― 10), 39.2 (CH, C ― 9), 38.5 (C, C ― 13), 27.7 (3C, CH 3 , C ― 3'), 26.9 (CH 3 , C ― 
29), 26.2 (CH 2 , C ― 12), 23.3 (CH 2 , C ― 6), 21.3 (CH 3 , C ― 28), 19.8 (CH 3 , C ― 30), 18.3 (CH 3 , C ― 18), 17.7 
(CH 3 , C ― 19), 15.0 (CH 2 , C ― 11); HRESIMS  m/z 563.2600 ([M＋Na] ＋ , calcd for C 31 H 40 O 8 Na, 563.2621). 
 3.2.2 Conversion of compound  2 into compound  4 
 　 Compound  2 (7.6 mg, 0.017 mmol) was dissolved in pyridine (1 mL), DMAP (0.5 mg, 0.0041 
mmol) and propionic anhydride {(CH 3 CH 2 CO) 2 O, 23 mg, 0.18 mmol} were added, and the resulting 
mixture was stirred for 24 h at room temperature.  The solvent was removed under reduced pressure 
and the resulting residue was purified using ODS HPLC (MeOH/H 2 O 70:30), resulting in compound  4 
(7.4 mg, 86%). 
 　 Compound  4 : Colorless, amorphous solid; [α] D27＋37 ( c 0.3, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 )δ
7.41 (1H, s, H ― 21), 7.41 (1H, d,  J ＝1.1 Hz, H ― 23), 7.09 (1H, d,  J ＝10.2 Hz, H ― 1), 6.34 (1H, s, H ― 22), 
5.86 (1H, d,  J ＝10.2 Hz, H ― 2), 5.60 (1H, s, H ― 17), 4.58 (1H, br s, H ― 7), 3.53 (1H, s, H ― 15), 2.49 (1H, 
dd,  J ＝12.7, 6.3 Hz, H ― 9), 2.35 (2H, m, H ― 2'), 2.17 (1H, dd,  J ＝13.2, 2.2 Hz, H ― 5), 2.00 (1H, m, H ― 11), 
1.91 (1H, m, H ― 6), 1.83 (1H, m, H ― 6), 1.82 (1H, m, H ― 11), 1.73 (1H, m, H ― 12), 1.60 (1H, m, H ― 12), 1.24 
(3H, s, H 3 ― 18), 1.22 (3H, s, H 3 ― 19), 1.19 (3H, m, H ― 3'), 1.16 (3H, s, H 3 ― 30), 1.07 (3H, s, H 3 ― 29), 1.05 
(3H, s, H 3 ― 28);  13 C-NMR (125 MHz, CDCl 3 ) δ 204.0 (C, C ― 3), 173.4 (C, C ― 1'), 167.4 (C, C ― 16), 157.0 
(CH, C ― 1), 143.1 (CH, C ― 23), 141.2 (CH, C ― 21), 126.0 (CH, C ― 2), 120.5 (C, C ― 20), 109.9 (CH, C ― 22), 
78.2 (CH, C ― 17), 72.8 (CH, C ― 7), 69.7 (C, C ― 14), 57.1 (CH, C ― 15), 46.1 (CH, C ― 5), 44.1 (C, C ― 4), 42.7 
(C, C ― 8), 40.1 (C, C ― 10), 39.6 (CH, C ― 9), 38.8 (C, C ― 13), 28.0 (CH 2 , C ― 2'), 27.2 (CH 3 , C ― 28), 26.0 (CH 2 , 
C ― 12), 23.3 (CH 2 , C ― 6), 21.2 (CH 3 , C ― 29), 19.8 (CH 3 , C ― 19), 18.4 (CH 3 , C ― 30), 17.8 (CH 3 , C ― 18), 15.0 
(CH 2 , C ― 11), 9.2 (CH 2 , C ― 3'); HRESIMS  m/z 497.2520 ([M＋H] ＋ , calcd for C 29 H 37 O 7 , 497.2539). 
 3.2.3 Conversion of compound  2 into compound  5 
 　 Compound  2 (12 mg, 0.028 mmol) was dissolved in pyridine (1 mL), DMAP (0.9 mg, 0.0074 mmol) 
and butyric anhydride {[CH 3 (CH 2 ) 2 CO] 2 O, 44 mg, 0.28 mmol} were added, and the resulting mixture 
was stirred for 24 h at room temperature.  The solvent was removed under reduced pressure and the 
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resulting residue was purified using ODS HPLC (MeOH/H 2 O 70:30), resulting in compound  5 (13 mg, 
93%). 
 　 Compound  5 : Colorless, amorphous solid; [α] D27＋42 ( c 0.6, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ
7.41 (2H, s, H ― 21 and H ― 23), 7.09 (1H, d,  J ＝10.2 Hz, H ― 1), 6.34 (1H, s, H ― 22), 5.86 (1H, d,  J ＝10.2 Hz, 
H ― 2), 5.60 (1H, s, H ― 17), 4.57 (1H, br s, H ― 7), 3.52 (1H, s, H ― 15), 2.49 (1H, dd, J＝12.7, 6.2 Hz, H ― 9), 
2.30 (2H, m, H ― 2'), 2.16 (1H, dd,  J ＝13.2, 2.1 Hz, H ― 5), 2.01 (1H, m, H ― 11), 1.92 (1H, m, H ― 6), 1.83 (1H, 
m, H ― 11), 1.81 (1H, m, H ― 6), 1.74 (1H, m, H ― 12), 1.67 (2H, m, H ― 3'), 1.60 (1H, m, H ― 12), 1.24 (3H, s, 
H 3 ― 18), 1.22 (3H, s, H 3 ― 19), 1.16 (3H, s, H 3 ― 30), 1.07 (3H, s, H 3 ― 29), 1.05 (3H, s, H 3 ― 28), 0.96 (3H, t,  J ＝
7.4 Hz, H ― 4');  13 C-NMR (125 MHz, CDCl 3 ) δ 204.0 (C, C ― 3), 172.6 (C, C ― 1'), 167.3 (C, C ― 16), 157.0 (CH, 
C ― 1), 143.1 (CH, C ― 23), 141.2 (CH, C ― 21), 126.0 (CH, C ― 2), 120.5 (C, C ― 20), 109.9 (CH, C ― 22), 78.2 
(CH, C ― 17), 72.8 (CH, C ― 7), 69.7 (C, C ― 14), 57.0 (CH, C ― 15), 46.0 (CH, C ― 5), 44.1 (C, C ― 4), 42.6 (C, C ― 
8), 40.1 (C, C ― 10), 39.5 (CH, C ― 9), 38.7 (C, C ― 13), 36.4 (CH 2 , C ― 2'), 27.2 (CH 3 , C ― 28), 26.0 (CH 2 , C ―
 12), 23.3 (CH 2 , C ― 6), 21.2 (CH 3 , C ― 29), 19.8 (CH 3 , C ― 19), 18.4 (CH 3 , C ― 30), 18.4 (CH 2 , C ― 3'), 17.8 (CH 3 , 
C ― 18), 15.0 (CH 2 , C ― 11), 13.8 (CH 3 , C ― 4'); HRESIMS  m/z 511.2707 ([M＋H] ＋  , calcd for C 30 H 39 O 7 , 
511.2696). 
 3.2.4 Conversion of compound  2 into compound  6 
 　 Compound  2 (13 mg, 0.030 mmol) was dissolved in dichloromethane (2 mL), DMAP (1.8 mg, 0.015 
mmol) and monochloroacetic acid anhydride {chloroacetic anhydride, (CH 2 ClCO) 2 O, 50 mg, 0.29 
mmol} were added, and the resulting mixture was stirred for 72 h at room temperature.  The solvent 
was removed under reduced pressure and the resulting residue was purified using ODS HPLC (MeOH/
H 2 O 65:35), resulting in compound  6 (9.3 mg, 66%). 
 　 Compound  6 : Colorless, amorphous solid; [α] D27＋44 ( c 0.5, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ
7.41 (1H, s, H ― 21), 7.41 (1H, d,  J ＝1.2 Hz, H ― 23), 7.09 (1H, d,  J ＝10.2 Hz, H ― 1), 6.34 (1H, s, H ― 22), 
5.87 (1H, d,  J ＝10.2 Hz, H ― 2), 5.62 (1H, s, H ― 17), 4.64 (1H, d,  J ＝1.2 Hz, H ― 7), 4.06 (2H, d,  J ＝1.8 Hz, 
H ― 2'), 3.51 (1H, m, H ― 15), 2.52 (1H, dd,  J ＝12.7, 6.3 Hz, H ― 9), 2.21 (1H, dd,  J ＝13.3, 2.3 Hz, H ― 5), 2.02 
(1H, m H ― 6), 2.00 (1H, m, H ― 11), 1.87 (1H, m, H ― 6), 1.85 (1H, m, H ― 11), 1.73 (1H, m, H ― 12β), 1.62 
(1H, m, H ― 12), 1.26 (3H, s, H 3 ― 18), 1.23 (3H, s, H 3 ― 19), 1.12 (3H, s, H 3 ― 30), 1.08 (6H, s, H 3 ― 28 and H 3 ― 
29);  13 C-NMR (125 MHz, CDCl 3 ) δ 203.8 (C, C ― 3), 167.3 (C, C ― 16), 166.3 (C, C ― 1'), 156.7 (CH, C ― 1), 
143.1 (CH, C ― 23), 141.2 (CH, C ― 21), 126.1 (CH, C ― 2), 120.3 (C, C ― 20), 109.9 (CH, C ― 22), 78.3 (CH, 
C ― 17), 75.2 (CH, C ― 7), 69.7 (C, C ― 14), 57.1 (CH, C ― 15), 45.9 (CH, C ― 5), 44.0 (C, C ― 4), 42.7 (C, C ― 8), 
40.6 (CH 2 , C ― 2'), 40.0 (C, C ― 10), C ― 9), 39.5 (CH, C ― 9), 38.9 (C, C ― 13), 27.3 (CH 3 , C ― 28), 25.9 (CH 2 , C ―
 12), 23.2 (CH 2 , C ― 6), 21.2 (CH 3 , C ― 29), 19.8 (CH 3 , C ― 19), 18.4 (CH 3 , C ― 30), 17.8 (CH 3 , C ― 18), 15.0 
(CH 2 , C ― 11); HRESIMS  m/z 517.1979 ([M＋H] ＋ , calcd for C 28 H 34 O 7 Cl, 517.1993). 
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 3.2.5 Conversion of compound  2 into compound  7 
 　 Compound  2 (12 mg, 0.028 mmol) was dissolved in dichloromethane (2 mL), DMAP (1.7 mg, 0.014 
mmol) and dichloroacetic anhydride {(CHCl 2 CO) 2 O, 48 μL, 0.27 mmol} were added, and the resulting 
mixture was stirred for 72 h at room temperature.  The solvent was removed under reduced pressure 
and the resulting residue was purified using ODS HPLC (MeOH/H 2 O 65:35), resulting in compound  7 
(7.8 mg, 53%). 
 　 Compound  7 : Colorless, amorphous solid; [α] D27＋ 28 ( c 0.4, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ
7.41 (2H, s, H ― 21 and H ― 23), 7.10 (1H, d,  J ＝8.6 Hz, H ― 1), 6.34 (1H, s, H ― 22), 5.96 (1H, s, H ― 2'), 5.87 
(1H, d,  J ＝8.6 Hz, H ― 2), 5.58 (1H, s, H ― 17), 4.65 (1H, br s, H ― 7), 3.53 (1H, s, H ― 15), 2.57 (1H, m, H ―
 9), 2.27 (1H, d-like,  J ＝3.2 Hz, H ― 5), 2.07 (1H, m, H ― 6), 2.04 (1H, m, H ― 11), 1.88 (1H, m, H ― 6), 1.85 
(1H, m, H ― 11), 1.73 (1H, m, H ― 12), 1.61 (1H, m, H ― 12), 1.25 (3H, s, H 3 ― 18), 1.24 (3H, s, H 3 ― 19), 1.23 
(3H, s, H 3 ― 30), 1,08 (3H, s, H 3 ― 29), 1.07 (3H, s, H 3 ― 28);  13 C-NMR (125 MHz, CDCl 3 ) δ 203.8 (C, C ― 3), 
166.6 (C, C ― 16), 163.3 (C, C ― 1'), 156.8 (CH, C ― 1), 143.1 (CH, C ― 23), 141.3 (CH, C ― 21), 126.2 (CH, C ― 
2), 120.3 (C, C ― 20), 109.9 (CH, C ― 22), 78.1 (CH, C ― 17), 76.4 (CH, C ― 7), 69.4 (C, C ― 14), 64.1 (CH, C ―
 2'), 57.5 (CH, C ― 15), 45.6 (CH, C ― 5), 44.1 (C, C ― 4), 42.8 (C, C ― 8), 40.1 (C, C ― 10), 39.2 (C, C ― 9), 38.7 
(C, C ― 13), 27.4 (CH 3 , C ― 28), 25.8 (CH 2 , C ― 12), 22.8 (CH 2 , C ― 6), 21.3 (CH 3 , C ― 29), 20.0 (CH 3 , C ― 19), 
18.6 (CH 3 , C ― 30), 17.9 (CH 3 , C ― 18), 15.1 (CH 2 , C ― 11); HRESIMS  m/z 551.1571 ([M＋H] ＋ , calcd for 
C 28 H 33 O 7 Cl 2 , 551.1603). 
 3.2.6 Conversion of compound  2 into compound  8 
 　 Compound  2 (12 mg, 0.027 mmol) was dissolved in dichloromethane (2 mL), DMAP (1.7 mg, 0.014 
mmol) and trichloroacetic anhydride {(CCl 3 CO) 2 O, 54 μL, 0.28 mmol} were added, and the resulting 
mixture was stirred for 72 h at room temperature.  The solvent was removed under reduced pressure 
and the resulting residue was purified using ODS HPLC (MeOH/H 2 O 65:35), resulting in compound  8 
(8.1 mg, 51%). 
 　 Compound  8 : Colorless, amorphous solid; [α] D27＋ 20 ( c 0.4, CHCl 3 );  1 H-NMR (500 MHz, CDCl 3 ) δ
7.40 (2H, s, H ― 21 and H ― 23), 7.09 (1H, d,  J ＝10.2 Hz, H ― 1), 6.33 (1H, d,  J ＝0.8 Hz, H ― 22), 5.86 (1H, d, 
 J ＝10.2 Hz, H ― 2), 5.56 (1H, s, H ― 17), 4.68 (1H, br s, H ― 7), 3.58 (1H, s, H ― 15), 2.55 (1H, dd,  J ＝12.2, 6.7 
Hz, H ― 9), 2.27 (1H, d-like,  J ＝13.4 Hz, H ― 5), 2.11 (1H, m, H ― 6), 2.00 (1H, m, H ― 11), 1.90 (1H, m, H ― 6), 
1.87 (1H, m, H ― 11), 1.74 (1H, m, H ― 12), 1.61 (1H, m, H ― 12), 1.24 (3H, s, H 3 ― 19), 1.23 (3H, s, H 3 ― 18), 
1.21 (3H, s, H 3 ― 30), 1.09 (3H, s, H 3 ― 28), 1.06 (3H, s, H 3 ― 29);  13 C-NMR (125 MHz, CDCl 3 )δ 203.7 (C, 
C ― 3), 166.4 (C, C ― 16), 160.9 (C, C ― 1'), 156.8 (CH, C ― 1), 143.1 (CH, C ― 23), 141.3 (CH, C ― 21), 126.1 
(CH, C ― 2), 120.2 (C, C ― 20), 109.9 (CH, C ― 22), 90.4 (C, C ― 2'), 78.8 (CH, C ― 7), 77.9 (CH, C ― 17), 69.3 (C, 
C ― 14), 57.8 (CH, C ― 15), 45.7 (CH, C ― 5), 44.1 (C, C ― 4), 43.0 (C, C ― 8), 40.2 (C, C ― 10), 39.2 (CH, C ― 9), 
The structure-activity relationship in a Gedunin-type Limonoid (7 ― Deacetoxy ― 7α―hydroxygedunin) with a modified functional group at the 7 ― position
― 33 ―
38.8 (C, C ― 13), 27.4 (CH 3 , C ― 28), 25.6 (CH 2 , C ― 12), 21.6 (CH 2 , C ― 6), 21.3 (CH 3 , C ― 29), 20.0 (CH 3 , C ―
 19), 18.4 (CH 3 , C ― 30), 17.7 (CH 3 , C ― 18), 15.0 (CH 2 , C ― 11); HRESIMS  m/z 585.1194 ([M＋H] ＋ , calcd 
for C 28 H 32 O 7 Cl 3 , 585.1214). 
 Acknowledgements 
 　 The authors wish to sincerely thank Drs. Koichi Takeya, Yukio Hitotsuyanagi, Yutaka Aoyagi, and 
Tomoyo Hasuda of the Department of Natural Products and Medicinal Chemistry, Tokyo University of 
Pharmacy and Life Sciences for their careful guidance and encouragement throughout the conduct of 
this study. 
 References 
 1 .  Khalid, S. A.; Duddeck, H.; Gonzalez-Sierra, M.  J. Nat. Prod .  1989 ,  52 , 922 ― 927. 
 2 .  MacKinnon, S.; Durst, T.; Arnason, J. T.; Angerhofer, C.; Pezzuto, J.; Sanchez-Vindas, P. E.; Poveda, L. J.; 
Gbeassor, M.  J. Nat. Prod.  1997 ,  60 , 336 ― 341. 
 3 .  Bray, D. H.; Warhurst, D. C.; Connolly, J. D.; O'Neill, M. J.; Phillipson, J. D.  Phytother. Res.  1990 ,  4 , 29 ― 35. 
 4 .  Saxena, S.; Pant, N.; Jain, D. C.; Bhakuni, R. S.;  Current Science  2003 ,  85 , 1314 ― 1329. 
 5 .  Nathan, S. S.; Kalaivani, K.; Murugan, K.  Acta Tropica  2005 ,  96 , 47 ― 55. 
 6 .  Suresh, G.; Gopalakrishnan, G.; Wesley, S. D.; Singh, N. D. P.; Malathi, R.; Rajan, S. S.  J Agric. Food Chem . 
 2002 ,  50 , 4484 ― 4490. 
 7 .  Mitsui, K.; Maejima, M.; Fukaya, H.; Hitotsuyanagi, Y.; Takeya, K. Limonoids from  Cedrela sinensis ; 
 Phytochemistry  2004 ,  65 , 3075 ― 3081. 
 8 .  Mitsui, K.; Saito, H.; Yamamura, R.; Fukaya Y.; Hitotsuyanagi, Y.; Takeya, K. Hydroxylated Gedunin 
Derivatives from  Cedrela sinensis ;  J. Nat. Prod .  2006 ,  69 , 1310 ― 1314. 
 9 .  Mitsui, K.; Maejima, M.; Fukaya, H.; Hitotsuyanagi, Y.; Takeya, K. Triterpenoids from  Cedrela sinensis ; 
 Tetrahedron  2005 ,  61 , 10569 ― 10582. 
 10.  Mitsui, K.; Saito, H.; Yamamura, R.; Fukaya Y.; Hitotsuyanagi, Y.; Takeya, K. Apotirucallane and Tirucallane 
Triterpenoids from  Cedrela sinensis ;  Chem. Pharm. Bull .  2007 ,  55 , 1442 ― 1447. 
 11.  Hitotsuyanagi, Y.; Mitsui K.; Fukaya Y.; Takeya K.;  Phytochemistry Letters  2012 ,  5 , 486 ― 489. 
 12.  Kim, I.H.; Takashima, S.; Hitotsuyanagi, Y.; Hasuda, T.; Takeya, K. New quassinoids, javanicolides C and D 
and javanicosides B-F, from seeds of  Brucea javanica ;  J. Nat. Prod .  2004 ,  67 , 863 ― 868. 
